Webinar, FAQ Report & Decision Aid | COVID-19 & Neuromuscular Disorders: Ask The Experts
Muscular Dystrophy Canada (MDC) and the Neuromuscular Disease Network for Canada (NMD4C) have received numerous questions about COVID-19 vaccines and how they may uniquely affect people with neuromuscular disorders (NMD).
To address these questions and concerns, MDC & NMD4C assembled a diverse group of neuromuscular, virology, and policy experts to host a webinar with the purpose of answering these topical questions.
From this expert-led webinar, the MDC & NMD4C have developed a frequently asked questions report and decision aid tool as resources to summarize the experts’ answers, and to provide guidance for informed patient decision making.
You can access the Frequently Asked Questions Report, Decision Aid, and webinar recording below!
Report: Frequently Asked Questions – COVID-19 & Neuromuscular Disorders
Decision Aid: I have a NMD, should I get a vaccine for COVID-19
We are excited to have the following experts address questions about NMDs, COVID-19 and vaccines:
- Dr. Hans Katzberg, adult neuromuscular specialist and NMD researcher
- Dr. Hanns Lochmuller, pediatric neuromuscular specialist and NMD researcher
- Dr. Reshma Amin, respirologist and NMD researcher
- Dr. Megan Bettle, Director of the COVID-19 Regulatory Response Team at Health Canada / Government of Canada
- Dr. Allison McGeer, Infectious Disease Specialist and COVID-19 researcher
- Dr. Anne Pham-Huy, Infectious Disease Specialist and Chair of Immunize Canada
Read next...
Muscular Dystrophy Canada Launches Initiative to Improve Genetic Testing Access for Myotonic Dystrophy
Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.
New Content Available in LEARNMD
LEARNMD is the NMD4C’s online educational platform, offering talks and sessions on a wide range of neuromuscular topics presented by leading clinical and scientific experts worldwide. We’re excited to share what’s new on LEARNMD in February 2025!
Quebec Network RĂ©seau QuĂ©bĂ©coise de l’Amyotrophie Spinale Joins NMD4C as Community of Practice Sub-Group
We are thrilled to announce that the RQAS, a network uniting rehabilitation clinicians across Quebec to advance the care of people with Spinal Muscular Atrophy has officially become a sub-group Community of Practice of the NMD4C
NMD4C 2024 Year in Review
This year in review outlines a collection of achievements from the network over the past year.
NMD4C and MDC Award Fellowship Funding in NMD Research and Medicine
Together the Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC) are excited to announce the 2025 recipients of our neuromuscular fellowship funding competition to award postdoctoral fellowships in neuromuscular disease (NMD) research and clinical fellowships in neuromuscular medicine and electromyography!
NMD4C Basic Science Trainee Committee Provides Leadership Opportunity for Next Generation of Neuromuscular Researchers
The newly-formed Basic Science Trainee Committee represents the interests of trainees within the network, offering an opportunity for professional growth for future leaders in neuromuscular research.